Published in Trends Cell Biol on July 01, 1997
SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J (2001) 4.32
A vacuolar v-t-SNARE complex, the predominant form in vivo and on isolated vacuoles, is disassembled and activated for docking and fusion. J Cell Biol (1998) 3.44
Flickering fusion pores comparable with initial exocytotic pores occur in protein-free phospholipid bilayers. Proc Natl Acad Sci U S A (1997) 2.25
Exocytosis and endocytosis Plant Cell (1999) 1.93
Vam7p, a vacuolar SNAP-25 homolog, is required for SNARE complex integrity and vacuole docking and fusion. EMBO J (1998) 1.89
A cell-free system for regulated exocytosis in PC12 cells. J Cell Biol (2000) 1.60
Vacuole acidification is required for trans-SNARE pairing, LMA1 release, and homotypic fusion. Proc Natl Acad Sci U S A (1999) 1.40
Post-priming actions of ATP on Ca2+-dependent exocytosis in pancreatic beta cells. Proc Natl Acad Sci U S A (1999) 1.29
Early requirement for alpha-SNAP and NSF in the secretory cascade in chromaffin cells. EMBO J (1999) 1.24
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine. Neurol Sci (2015) 0.99
Rapid regulated dense-core vesicle exocytosis requires the CAPS protein. Proc Natl Acad Sci U S A (2000) 0.96
SNAP-23 participates in SNARE complex assembly in rat adipose cells. Biochem J (1999) 0.92
Presynaptic mitochondria and the temporal pattern of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci (1999) 0.89
Vacuolar sequential exocytosis of large dense-core vesicles in adrenal medulla. EMBO J (2006) 0.89
CAPS and Munc13: CATCHRs that SNARE Vesicles. Front Endocrinol (Lausanne) (2013) 0.89
Synchronized ATP oscillations have a critical role in prechondrogenic condensation during chondrogenesis. Cell Death Dis (2012) 0.85
Green light for the secretory pathway. Protoplasma (1999) 0.77
Dual Monitoring of Secretion and ATP Levels during Chondrogenesis Using Perfusion Culture-Combined Bioluminescence Monitoring System. Biomed Res Int (2015) 0.75
Cloning and sequencing of a protein involved in phagosomal membrane fusion in Paramecium. Mol Biol Cell (1999) 0.75
Selection and preference for botulinum toxins in the management of photoaging and facial lines: patient and physician considerations. Patient Prefer Adherence (2010) 0.75
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations. J Pain Res (2017) 0.75
ATP-dependent inositide phosphorylation required for Ca(2+)-activated secretion. Nature (1995) 3.30
Synaptotagmin modulation of fusion pore kinetics in regulated exocytosis of dense-core vesicles. Science (2001) 2.73
Phosphatidylinositol transfer protein required for ATP-dependent priming of Ca(2+)-activated secretion. Nature (1993) 2.28
A novel 145 kd brain cytosolic protein reconstitutes Ca(2+)-regulated secretion in permeable neuroendocrine cells. Cell (1992) 2.20
PIP kinase Igamma is the major PI(4,5)P(2) synthesizing enzyme at the synapse. Neuron (2001) 2.13
Resolution of regulated secretion into sequential MgATP-dependent and calcium-dependent stages mediated by distinct cytosolic proteins. J Cell Biol (1992) 2.06
Thyrotropin-releasing hormone activates a Ca2+-dependent polyphosphoinositide phosphodiesterase in permeable GH3 cells. GTP gamma S potentiation by a cholera and pertussis toxin-insensitive mechanism. J Biol Chem (1986) 1.77
N-Ethylmaleimide-sensitive factor acts at a prefusion ATP-dependent step in Ca2+-activated exocytosis. J Biol Chem (1996) 1.65
Yeast Sec14p deficient in phosphatidylinositol transfer activity is functional in vivo. Mol Cell (1999) 1.60
The C terminus of SNAP25 is essential for Ca(2+)-dependent binding of synaptotagmin to SNARE complexes. J Biol Chem (2000) 1.58
G protein betagamma subunit-mediated presynaptic inhibition: regulation of exocytotic fusion downstream of Ca2+ entry. Science (2001) 1.51
Novel Ca2+-binding protein (CAPS) related to UNC-31 required for Ca2+-activated exocytosis. J Biol Chem (1997) 1.49
The C2B domain of synaptotagmin is a Ca(2+)-sensing module essential for exocytosis. J Cell Biol (2000) 1.45
Synaptic vesicle ceramide kinase. A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles. J Biol Chem (1989) 1.37
CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis. Neuron (1998) 1.36
Docking and fusion in neurosecretion. Curr Opin Cell Biol (1998) 1.32
Drosophila CAPS is an essential gene that regulates dense-core vesicle release and synaptic vesicle fusion. Neuron (2001) 1.30
Specific binding of phosphatidylinositol 4,5-bisphosphate to calcium-dependent activator protein for secretion (CAPS), a potential phosphoinositide effector protein for regulated exocytosis. J Biol Chem (1998) 1.27
SNAP-25 is required for a late postdocking step in Ca2+-dependent exocytosis. J Biol Chem (1996) 1.24
Differential regulation of exocytosis by calcium and CAPS in semi-intact synaptosomes. Neuron (1998) 1.20
Direct stimulation by thyrotropin-releasing hormone (TRH) of polyphosphoinositide hydrolysis in GH3 cell membranes by a guanine nucleotide-modulated mechanism. Biochem Biophys Res Commun (1985) 1.16
A key role for a 145-kDa cytosolic protein in the stimulation of Ca(2+)-dependent secretion by protein kinase C. J Biol Chem (1992) 1.09
Protein kinase C translocates from cytosol to membrane upon hormone activation: effects of thyrotropin-releasing hormone in GH3 cells. Biochem Biophys Res Commun (1985) 1.09
Thyrotropin-releasing hormone rapidly and transiently stimulates cytosolic calcium-dependent protein phosphorylation in GH3 pituitary cells. J Biol Chem (1982) 1.09
Priming in exocytosis: attaining fusion-competence after vesicle docking. Biochimie (2000) 1.08
Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11. Mol Endocrinol (1992) 1.07
Thyrotropin-releasing hormone mobilizes Ca2+ from endoplasmic reticulum and mitochondria of GH3 pituitary cells: characterization of cellular Ca2+ pools by a method based on digitonin permeabilization. Proc Natl Acad Sci U S A (1982) 1.02
Thyrotropin-releasing hormone (TRH) selectively and rapidly stimulates phosphatidylinositol turnover in GH pituitary cells: a possible second step of TRH action. Endocrinology (1982) 1.00
Botulinum neurotoxin light chain inhibits norepinephrine secretion in PC12 cells at an intracellular membranous or cytoskeletal site. J Neurochem (1991) 1.00
Thyrotropin-releasing hormone stimulation of polyphosphoinositide hydrolysis in GH3 cell membranes is GTP dependent but insensitive to cholera or pertussis toxin. J Biol Chem (1986) 1.00
Large dense-core vesicle exocytosis in PC12 cells. Methods (1998) 0.99
Rapid regulated dense-core vesicle exocytosis requires the CAPS protein. Proc Natl Acad Sci U S A (2000) 0.96
Cell cracking: permeabilizing cells to macromolecular probes. Methods Enzymol (1989) 0.94
Measurement of phospholipid turnover in cultured hormone responsive pituitary cells. Methods Enzymol (1986) 0.92
Evidence for the role of calcium and diacylglycerol as dual second messengers in thyrotropin-releasing hormone action: involvement of diacylglycerol. Endocrinology (1984) 0.90
Extended RNA synthesis in isolated nuclei from rat pituitary tumor cells. Biochemistry (1976) 0.90
Ca(2+)-dependent activator protein for secretion is critical for the fusion of dense-core vesicles with the membrane in calf adrenal chromaffin cells. J Neurosci (1999) 0.88
Thyrotropin-releasing hormone rapidly activates protein phosphorylation in GH3 pituitary cells by a lipid-linked, protein kinase C-mediated pathway. J Biol Chem (1984) 0.88
Thyrotropin-releasing hormone and cyclic AMP activate distinctive pathways of protein phosphorylation in GH pituitary cells. J Biol Chem (1982) 0.87
Thyrotropin-releasing hormone modulation of uridine uptake in rat pituitary cells. Evidence that uridine phosphorylation is regulated. J Biol Chem (1978) 0.87
Evidence for the role of calcium and diacylglycerol as dual second messengers in thyrotropin-releasing hormone action: involvement of Ca+2. Endocrinology (1984) 0.86
Characterization of Ca2+-stimulated secretion in permeable GH3 pituitary cells. J Biol Chem (1986) 0.86
Prolactin secretion in permeable GH3 pituitary cells is stimulated by Ca2+ and protein kinase C activators. Biochem Biophys Res Commun (1985) 0.85
Thy-1 is a component common to multiple populations of synaptic vesicles. J Cell Biol (1998) 0.85
Hormone-regulated phosphoinositide turnover in permeabilized cells and membranes. Methods Enzymol (1987) 0.81
Growth inhibition by adenosine 3',5-monophosphate derivatives does not require 3',5' phosphodiester linkage. Science (1981) 0.80
Characterization of phorbol ester- and diacylglycerol-stimulated secretion in permeable GH3 pituitary cells. Interaction with Ca2+. J Biol Chem (1986) 0.80
Protein transport. Greasing the Golgi budding machine. Nature (1997) 0.79
Multiple mechanisms of growth inhibition by cyclic AMP derivatives in rat GH1 pituitary cells: isolation of an adenylate cyclase-deficient variant. J Cell Physiol (1981) 0.79
Paradoxical effects of protein synthesis inhibitors on uridine uptake in cultured cells: possible role of uncharged tRNA in regulating metabolism. J Cell Physiol (1980) 0.78
Nerve growth factor induces sensitivity to botulinum neurotoxin type A in norepinephrine-secreting PC12 cells. Neurosci Lett (1993) 0.78
Racing lipid rafts for synaptic-vesicle formation. Nat Cell Biol (2000) 0.78
Calcium-dependent release of norepinephrine from permeabilized PC12 cells is inhibited by approximately 48 and approximately 112 kDa fragments of botulinum neurotoxin type E. Neuropharmacology (1993) 0.78
Thyrotropin-releasing hormone modulation of uridine uptake in rat pituitary cells. Characterization of the responses. J Biol Chem (1978) 0.77
Relationship between clinical features of acute myocardial infarction and ventricular runs 2 weeks to 1 year after infarction. Circulation (1981) 0.75
Mortality of myocardial infarction treated in the coronary-care unit. Heart Lung (1975) 0.75
Physicians' views of Catholic hospitals: a roundtable. Hosp Prog (1983) 0.75
Phosphoinositide hydrolysis in response to the withdrawal of dopamine inhibition in enriched lactotrophs in culture. Neuroendocrinology (1987) 0.75
Dopamine withdrawal and addition of thyrotropin-releasing hormone stimulate membrane translocation of protein kinase-C and phosphorylation of an endogenous 80K substrate in enriched lactotrophs. Endocrinology (1989) 0.75